Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by forhandlarenon Nov 02, 2022 2:21am
757 Views
Post# 35065301

Meaning of rapid growth?

Meaning of rapid growth?I'm sure that we all bought our shares based in the idea that value would increase - and because it's biotech we should expect to wait for some time - and because of the implied risk we would get better return on our investment compared to other sectors.

In short, we all want this company to be successful.

Now, what does rapid growth mean?

My initial interpretation was that H2 2022 would include
1) great street cred was earned that would boost self-confidence in negotiations, which remain to be seen in pet SQLT2 
2) great up-front would boost share price
3) rapid expansion of the lab and hire twice as many resources
4) possibly an milestone from Abbvie
5) self funding of anti-aging trial

Unfortunately, and immature, the management does not communicate with shareholders bi-directional so we can only speculate.

It strikes me that Howard only referred to the machine they bought for the lab? Now the can accelerate research, but revenue from this is of course years away.

Is he just a dreamer or is there any substance behind his statement of rapid growth? The issue for me as an investor is that I don't know. Track record points at dreamer, but H2 is not over yet so I cannot completely rule out a positive surprise.

My only hope is that the hospital colleagues that bought into this dream express disappointment and force him socially to mature and start to build value for this company in terms of share price - and communicate bi-directional. Would be absolutely fantastic of one could reach out to them...

Well, maybe the chinese investors that bought at 40 cents will give him some heat as well.

I'm fed up with carrots - now I really want to understand what I have invested in, because obviously me and Howard have a very different view on rapid growth, 13 cents does not cut it.
<< Previous
Bullboard Posts
Next >>